✦ LIBER ✦

Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1

✍ Scribed by Hari S. Conjeevaram; Michael W. Fried; Lennox J. Jeffers; Norah A. Terrault; Thelma E. Wiley–Lucas; Nezam Afdhal; Robert S. Brown; Steven H. Belle; Jay H. Hoofnagle; David E. Kleiner; Charles D. Howell

Book ID: 119759354
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 133 KB
Volume: 131
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon Pharmacokinetics in Africa

Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection

✍ Howell, Charles D.; Dowling, Thomas C.; Paul, Marika; Wahed, Abdus S.; Terrault, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 599 KB

829 Ribavirin Population Pharmacokinetic

829 Ribavirin Population Pharmacokinetics in African American and Caucasian American Patients Infected with Chronic Hepatitis C Genotype 1

✍ Jin, Runyan; Fossler, Michael J.; Dowling, Thomas; Howell, Charles D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 87 KB

The pharmacokinetics of peginterferon al

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C

✍ B. J. Brennan; P. N. Morcos; K. Wang; S. D. Blotner; R. Morrison; C. H. Hagedorn 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

332 Peginterferon alfa-2A (40KD) (PEGASY

332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

✍ Charles Howell; Lennox S. Jeffers; William Cassidy; K. Rajender Reddy; Susan She 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Impact of weight-based ribavirin with pe

Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1

✍ Ira M. Jacobson; Robert S. Brown Jr; Jonathan McCone; Martin Black; Clive Albert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

Brass, 14 for the WIN-R Study Group WIN-R (Weight-based dosing of pegINterferon alfa-2b and Ribavirin) was a multicenter, randomized, open-label, investigator-initiated trial involving 236 community and academic sites in the United States, comparing response to pegylated interferon (PEG-IFN) alfa-2b

190 Interferon-stimulated gene expressio

190 Interferon-stimulated gene expression and virological response during peginterferon ALFA-2A and ribavirin treatment in African American and Caucasian HCV genotype 1 patients

✍ Charles D. Howell; Shengyuan Luo; William Cassidy; Lennox Jeffers; Rajender Redd 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB